{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:38:37Z","timestamp":1777477117114,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270933"],"award-info":[{"award-number":["81270933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"crossref","award":["2012CB524906"],"award-info":[{"award-number":["2012CB524906"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-015-0171-6","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T01:54:36Z","timestamp":1452909276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis"],"prefix":"10.1186","volume":"15","author":[{"given":"Jingjing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abudurexiti","family":"Kayoumu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"key":"171_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","volume":"272","author":"RP Surendran","year":"2012","unstructured":"Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med. 2012;272:185\u201396.","journal-title":"J Intern Med"},{"key":"171_CR2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.ATV.19.3.472","volume":"19","author":"MC Jong","year":"1999","unstructured":"Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol. 1999;19:472\u201384.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"171_CR3","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM197812282992601","volume":"299","author":"DW Cox","year":"1978","unstructured":"Cox DW, Breckenridge WC, Little JA. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med. 1978;299:1421\u20134.","journal-title":"N Engl J Med"},{"key":"171_CR4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM197806082982301","volume":"298","author":"WC Breckenridge","year":"1978","unstructured":"Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978;298:1265\u201373.","journal-title":"N Engl J Med"},{"key":"171_CR5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11248-010-9467-5","volume":"20","author":"Y Ding","year":"2011","unstructured":"Ding Y, Wang Y, Zhu H, Fan J, Yu L, Liu G, et al. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII. Transgenic Res. 2011;20:867\u201375.","journal-title":"Transgenic Res"},{"key":"171_CR6","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1073\/pnas.81.20.6354","volume":"81","author":"SS Fojo","year":"1984","unstructured":"Fojo SS, Law SW, Brewer Jr HB. Human apolipoprotein C-II: complete nucleic acid sequence of preapolipoprotein C-II. Proc Natl Acad Sci U S A. 1984;81:6354\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"171_CR7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI113246","volume":"80","author":"PW Connelly","year":"1987","unstructured":"Connelly PW, Maguire GF, Little JA. Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest. 1987;80:1597\u2013606.","journal-title":"J Clin Invest"},{"key":"171_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jmg.25.10.649","volume":"25","author":"DW Cox","year":"1988","unstructured":"Cox DW, Wills DE, Quan F, Ray PN. A deletion of one nucleotide results in functional deficiency of apolipoprotein CII (apo CII Toronto). J Med Genet. 1988;25:649\u201352.","journal-title":"J Med Genet"},{"key":"171_CR9","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0006-291X(90)91145-I","volume":"168","author":"C Crecchio","year":"1990","unstructured":"Crecchio C, Capurso A, Pepe G. Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari). Biochem Biophys Res Commun. 1990;168:1118\u201327.","journal-title":"Biochem Biophys Res Commun"},{"key":"171_CR10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI113756","volume":"82","author":"SS Fojo","year":"1988","unstructured":"Fojo SS, Beisiegel U, Beil U, Higuchi K, Bojanovski M, Gregg RE, et al. Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency. J Clin Invest. 1988;82:1489\u201394.","journal-title":"J Clin Invest"},{"key":"171_CR11","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1016\/S0021-9258(19)30009-2","volume":"264","author":"SS Fojo","year":"1989","unstructured":"Fojo SS, de Gennes JL, Chapman J, Parrott C, Lohse P, Kwan SS, et al. An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem. 1989;264:20839\u201342.","journal-title":"J Biol Chem"},{"key":"171_CR12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI114287","volume":"84","author":"SS Fojo","year":"1989","unstructured":"Fojo SS, Lohse P, Parrott C, Baggio G, Gabelli C, Thomas F, et al. A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency. J Clin Invest. 1989;84:1215\u20139.","journal-title":"J Clin Invest"},{"key":"171_CR13","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1016\/S0021-9258(19)81302-9","volume":"263","author":"SS Fojo","year":"1988","unstructured":"Fojo SS, Stalenhoef AF, Marr K, Gregg RE, Ross RS, Brewer Jr HB. A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem. 1988;263:17913\u20136.","journal-title":"J Biol Chem"},{"key":"171_CR14","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1006\/bbrc.1993.1749","volume":"193","author":"H Inadera","year":"1993","unstructured":"Inadera H, Hibino A, Kobayashi J, Kanzaki T, Shirai K, Yukawa S, et al. A missense mutation (Trp 26-->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama). Biochem Biophys Res Commun. 1993;193:1174\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"171_CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cca.2005.07.025","volume":"364","author":"CW Lam","year":"2006","unstructured":"Lam CW, Yuen YP, Cheng WF, Chan YW, Tong SF. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome. Clin Chim Acta. 2006;364:256\u20139.","journal-title":"Clin Chim Acta"},{"key":"171_CR16","first-page":"148","volume":"438C","author":"M Okubo","year":"2014","unstructured":"Okubo M, Toromanovic A, Ebara T, Murase T. Apolipoprotein C-II : a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency. Clin Chim Acta. 2014;438C:148\u201353.","journal-title":"Clin Chim Acta"},{"key":"171_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-2275(20)41526-3","volume":"33","author":"CL Parrott","year":"1992","unstructured":"Parrott CL, Alsayed N, Rebourcet R, Santamarina-Fojo S. ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome. J Lipid Res. 1992;33:361\u20137.","journal-title":"J Lipid Res"},{"key":"171_CR18","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/S0022-2275(20)37463-0","volume":"37","author":"R Streicher","year":"1996","unstructured":"Streicher R, Geisel J, Weisshaar C, Avci H, Oette K, Muller-Wieland D, et al. A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia. J Lipid Res. 1996;37:2599\u2013607.","journal-title":"J Lipid Res"},{"key":"171_CR19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10598","volume":"53","author":"CJ Wilson","year":"2003","unstructured":"Wilson CJ, Priore Oliva C, Maggi F, Catapano AL, Calandra S. Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy. Ann Neurol. 2003;53:807\u201310.","journal-title":"Ann Neurol"},{"key":"171_CR20","first-page":"383","volume":"48","author":"WJ Xiong","year":"1991","unstructured":"Xiong WJ, Li WH, Posner I, Yamamura T, Yamamoto A, Gotto Jr AM, et al. No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles. Am J Hum Genet. 1991;48:383\u20139.","journal-title":"Am J Hum Genet"},{"key":"171_CR21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2362.1992.tb01941.x","volume":"22","author":"FU Beil","year":"1992","unstructured":"Beil FU, Fojo SS, Brewer Jr HB, Greten H, Beisiegel U. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism. Eur J Clin Invest. 1992;22:88\u201395.","journal-title":"Eur J Clin Invest"},{"key":"171_CR22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2362.1993.tb00960.x","volume":"23","author":"C Gabelli","year":"1993","unstructured":"Gabelli C, Bilato C, Santamarina-Fojo S, Martini S, Brewer Jr HB, Crepaldi G, et al. Heterozygous apolipoprotein C-II deficiency: lipoprotein and apoprotein phenotype and RsaI restriction enzyme polymorphism in the Apo C-IIPadova kindred. Eur J Clin Invest. 1993;23:522\u20138.","journal-title":"Eur J Clin Invest"},{"key":"171_CR23","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI117151","volume":"93","author":"NS Shachter","year":"1994","unstructured":"Shachter NS, Hayek T, Leff T, Smith JD, Rosenberg DW, Walsh A, et al. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J Clin Invest. 1994;93:1683\u201390.","journal-title":"J Clin Invest"},{"key":"171_CR24","doi-asserted-by":"crossref","unstructured":"Sakurai T, Sakurai A, Vaisman BL, Amar MJ, Liu C, Gordon SM, et al. Creation of ApoC-II mutant mice and correction of their Hypertriglyceridemia with an ApoC-II mimetic peptide. J Pharmacol Exp Ther. 2015.","DOI":"10.1124\/jpet.115.229740"},{"key":"171_CR25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI112332","volume":"77","author":"G Baggio","year":"1986","unstructured":"Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, et al. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest. 1986;77:520\u20137.","journal-title":"J Clin Invest"},{"key":"171_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1592\/phco.20.4.270.34882","volume":"20","author":"AM Heck","year":"2000","unstructured":"Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy. 2000;20:270\u20139.","journal-title":"Pharmacotherapy"},{"key":"171_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0002-9149(01)02208-1","volume":"89","author":"AS Wierzbicki","year":"2002","unstructured":"Wierzbicki AS, Reynolds TM, Crook MA. Usefulness of Orlistat in the treatment of severe hypertriglyceridemia. Am J Cardiol. 2002;89:229\u201331.","journal-title":"Am J Cardiol"}],"updated-by":[{"DOI":"10.1186\/s12944-016-0206-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000}}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0171-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T19:49:00Z","timestamp":1654112940000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.lipidworld.com\/content\/15\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0171-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12944-016-0206-7","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]},"article-number":"12"}}